appropriations

Dear Research Advocate, With so much going on in -- and about -- Washington, D.C., it’s easy to overlook the matter of still-unresolved FY17 appropriations. There are members of Congress on both sides of the aisle and in both chambers calling for completion of those bills, and we agree. That’s what our elected representatives should be doing instead of kicking the can down the road with yet another extension of the continuing resolution (CR). Yes, it’s true that if Congress takes up work to complete FY17 spending bills, members will be tasked with developing FY17 and FY18 bills at the same time. Some think this will be difficult for the Senate, with its schedule packed with confirmation...
Dear Research Advocate, Thanks for your indulgence; I’m afraid we’ve been flooding your inbox over the past few days. Most recently, we sent an email moving up the deadline for signing on to a letter to congressional leaders urging them to refrain from passing another Continuing Resolution (CR), and to instead complete their work on FY17 appropriations. We sent that letter out tonight, proximal to today’s announcement by House Appropriations Chairman Hal Rogers (R-KY) that he will in fact pursue a CR that would flat-fund government until March of next year (further delaying, and potentially squandering, any increase in funding for NIH and other health agencies in FY17). While his...
Dear Research Advocate: Monday’s presidential debate had a promising start when, during her opening remarks, Secretary Clinton listed “innovation and technology” as an investment priority, but neither candidate touched on the need for faster medical progress or a rock solid public health system. Read more on the debate on our Campaign for Cures blog . If you feel so inclined, tweet Mr. Trump (@realDonaldTrump) and Secretary Clinton (@HillaryClinton) and ask them to make use of the next debate to tell Americans what they will do to fight health threats - ongoing like cancer and emerging like Zika - that rob Americans of time, independence and hope. Do the same for vice presidential...
Dear Research Advocate: I am sending my letter out early this week to ensure you can tune into our National Health Research Forum, Straight Talk: New Thinking on Tough Challenges , which will take place tomorrow at 11:45 a.m. ET at the Newseum in Washington, DC. Our expert moderators will press panelists -- top federal officials and other key leaders from across the research ecosystem -- on critical, complex and in some cases, controversial topics in health, research and innovation. It is sure to be a riveting discussion not to be missed. While the Forum is sold out, you can watch virtually with our event live-stream hosted by WebMD. With Congress returning from recess and the end of fiscal...
Dear Research Advocate: The number of Zika cases continues to rise and mosquito season won’t be over anytime soon. Yet Congress hasn’t acted -- a good reason to maintain a permanent public health emergency fund. We have such funds for weather-related emergencies like hurricanes and floods, enabling immediate action whether or not Congress is in session, and we have a similar funding mechanism for public health emergencies...the problem is, there are no dollars in it. Rep. Rosa DeLauro (D-CT-03) introduced legislation earlier this year, the Public Health Emergency Preparedness Act (H.R. 4525), to provide $5 billion for such a fund. “Labor-H” Subcommittee Chairman Tom Cole (R-OK-04) has also...
Dear Research Advocate: Earlier this week, the House passed an inadequate proposal for $622.1 million in emergency Zika funding, falling far short of the bipartisan Senate proposal of $1.1 billion passed this week, not to mention the President’s request of $1.9 billion. Appropriations subcommittee Chairman Cole (R-OK-04) has stated that subsequent Zika funding will come in the next appropriations cycle, but public health experts tell us we cannot wait. (This is especially true since the pattern of the last many years is for appropriations to go undetermined until almost calendar year end.) Summer months are approaching and half the continental U.S. is home to potential disease-carrying...
Dear Research Advocate: Despite their fierce partisan standoff regarding confirmation of a Supreme Court nominee, members of the Senate acted in a strongly bi partisan manner yesterday to confirm Robert M. Califf, M.D., as the new FDA Commissioner. Dr. Califf brings an accomplished career of expertise and insight to the position. The goals he has set include increasing patient involvement in the FDA regulatory process, streamlining clinical trials, and attracting and retaining the best scientists, according to STAT News . For more on Dr. Califf’s confirmation, please see my statement . Commissioner Califf will be joining us as a keynote speaker at Research!America’s Annual Meeting at noon...
Dear Research Advocate: Now that the President has signed off on the budget agreement, Appropriations Committee leadership is negotiating to establish the dollar level for each appropriations subcommittee to work with. Given the December 11 deadline for action, the committees are already working to set allocations for each federal agency and program. Here is a list of the Twitter handles for each House and Senate appropriator, along with suggested tweets. Please take a minute to tweet these leaders on why it is so important to increase funding for NIH, CDC, FDA, AHRQ and NSF; federal agencies that help keep the wheels of science and medical progress turning! It’s a mistake to just assume...
Dear Research Advocate, It was a privilege to address the terrific crowd at last night’s kick off reception for the American Association for Cancer Research (AACR) Rally for Medical Research. Forceful champions including Senators Durbin (D-IL), Moran (R-KS), Murray (D-WA) and Klobuchar (D-MN) joined NIH Director Francis Collins to thank and encourage the more than 300 advocates who are blanketing both Houses of Congress today. Adding in social media attention, the Rally is likely to reach every member of Congress. During remarks at a Rally breakfast this morning, House “Labor-H” Appropriations Subcommittee Chairman Tom Cole (R-OK-04) revved up the crowd when he said that “the stars are...
Dear Research Advocate: After years of attending to other priorities and taking an “on cruise-control” approach to science, Congress has turned the corner with enthusiasm and determination! Clay Alspach and Tim Pataki from Energy and Commerce Chairman Upton’s staff joined Research!America members on Tuesday to discuss 21st Century Cures. They asked us to help assure a robust and bipartisan list of cosponsors for the bill. Please take a moment to ask your representative to sign-on, or thank him or her for cosponsoring. Please also consider joining one, two or all three of these sign-on letters: UMR , Ad Hoc , NHC . We have final figures for the joint online survey by The Science Advisory...

Sidebar Quote

Without continued support for health research, many of the most promising young scientists, their ideas and a myriad of potentially life-changing scientific breakthroughs will vanish into oblivion.
Paul Marinec, PhD; University of California San Francisco